Showing results (21-30 of 447) with videos related to

Sort By:
Pageof 45
Cancer Immunology, Immunotherapy : CII|June 28, 2021
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumabHitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2024
Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysisKentaro Tamura, Yusuke Okuma, Shogo Nomura, et al.
Journal of Cancer Research and Clinical Oncology|July 25, 2020
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expressionKen Masuda, Hidehito Horinouchi, Midori Tanaka, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modificationYukiko Igawa, Tatsuya Yoshida, Reiko Makihara, et al.
Clinical Lung Cancer|December 10, 2003
Results of recent Japanese clinical trials in lung cancerYuichiro Ohe, Nagahiro Saijo
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Treatment of lung cancer using immune checkpoint inhibitorsHideaki Shiraishi, Yuichiro Ohe
Japanese Journal of Clinical Oncology|March 3, 2020
History of Japan Clinical Oncology Group (JCOG) Lung Cancer Study GroupHidehito Horinouchi, Yuichiro Ohe
Japanese Journal of Clinical Oncology|January 3, 2022
Performance of Japanese patients in registrational studiesYasushi Goto, Sayaka Arakawa, Masayuki Shirasawa, et al.
Pageof 45